Navigation Links
Watson Files Application for Generic SEASONIQUE(R)
Date:3/4/2008

CORONA, Calif., March 4 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its levonorgestrel and ethinyl estradiol (0.15 mg/0.03 mg) extended-cycle oral contraceptive product, prior to the expiration of patents owned by Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. Watson's levonorgestrel and ethinyl estradiol product is a generic version of Barr's SEASONIQUE(R).

On January 23, 2008 pursuant to the Hatch-Waxman Act, Watson notified Barr that it had filed an ANDA with a paragraph IV certification with the FDA for a generic version of SEASONIQUE(R) asserting that the SEASONIQUE(R) patent is invalid or not infringed. Based on available information, Watson believes it may be the first applicant to file an ANDA for SEASONIQUE(R) and, should its product be approved, may be entitled to 180 days of generic market exclusivity.

SEASONIQUE(R) is indicated for the prevention of pregnancy.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, patents and other intellectual property rights held by competitors and other third parties and the uncertainty of the outcome of litigation related to such patents and intellectual property rights; the difficulty of predicting the timing or outcome of product development efforts and FDA or other regulatory agency approvals or actions; the impact of competitive products and pricing; market acceptance of and continued demand for Watson's products; difficulties or delays in manufacturing; and other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Annual Report on Form 10-K for the year ended December 31, 2007.

SEASONIQUE(R) is a registered trademark of Duramed Pharmaceuticals, Inc.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2019)... ... January 08, 2019 , ... ... South DeKalb and West End communities have a new option for their medical ... network, effective immediately. , JenCare operates five centers in Atlanta that provide access ...
(Date:1/8/2019)... ... ... In Partnership with the Smiles for Everyone Foundation , Perfect Smile ... NV on February 2. , Dental services provided include same-day procedures such ... Smiles for Everyone Foundation website . , About P3 Dental Group, P3 ...
(Date:1/7/2019)... ... January 07, 2019 , ... byte is ... destined to improve smiles and physical health across the nation. byte is an ... have a brighter and straighter smile being treated by leading orthodontists and the ...
(Date:1/7/2019)... ... January 07, 2019 , ... Crunch Waco is kicking of 2019 with an exciting grand ... Award winning quarterback at the University of Texas, Young went on to play six seasons ... Rose Bowl Hall of Fame. , Young will be on hand to sign autographs ...
(Date:1/7/2019)... ... January 07, 2019 , ... ... is a gripping memoir following the author and her husband as they adopt ... as children whose parents used drugs either in utero or in infancy, is ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... , ... January 10, 2019 , ... ... company providing nutrition and lifestyle solutions, will crown the U.S. winner of its ... 15 finalists include: Andrea Carrara of Palm Beach, Florida; Barbara Lingle of Winterville, ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... ... have been trending towards wellness-oriented lifestyles for their residents. Now the findings of ... has been reached. , Conducted by the International Council on Active Aging® (ICAA), ...
(Date:1/7/2019)... ... January 07, 2019 , ... Dr. Joseph J. Rousso is a ... in New York City. He is certified by the American Board of Facial Plastic ... menu of both surgical and non-surgical procedures for the face and neck. Dr. Rousso ...
Breaking Medicine Technology: